Guidelines to Practice

Updated guidelines for immune thrombocytopenic purpura: Expanded management options

Sherwin DeSouza, MD and Dana Angelini, MD
Cleveland Clinic Journal of Medicine December 2021, 88 (12) 664-668; DOI: https://doi.org/10.3949/ccjm.88a.20201

Article Information

vol. 88 no. 12 664-668
DOI 
https://doi.org/10.3949/ccjm.88a.20201
PubMed 
34857604
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online December 2, 2021.
Copyright & Usage 
Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Sherwin DeSouza, MD
  1. Department of Hematology/Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH
  1. Dana Angelini, MD⇑
  1. Associate Staff, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
  1. Address:
    Dana Angelini, MD, Department of Hematology and Medical Oncology, CA-60, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; angelid{at}ccf.org
View Abstract
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects